SVRA
SavaraDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
SVRA vs peer average
32/100
SVRA vs. peer average (D vs. C)
Grade spread
A 3 · B 2 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ANAB is the first available peer comparator.
Small-cap biotech with similar market value; useful mainly as a single-program/event-risk comparator rather than an indication match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SVRA
Savara
ANAB
AnaptysBio
Grade
D
A
Momentum
39
95
Value
41
41
Sentiment
58
53
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ANAB
SVRA / ANAB
Grade Position
Below peers
SVRA vs. peer average (D vs. C)
32/100
Momentum
39
ANABValue
41
SVRASentiment
58
SVRARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SVRA
ANAB is the first peer returned for this comparison set.

